About Cargo Therapeutics
Cargo Therapeutics is a Healthcare company based in San Mateo (United States) founded in 2021 by Louai Labanieh, Robbie Majzner, and Nancy Goodman, and was acquired by Concentra Biosciences in July 2025. Cell-based therapeutics for cancer treatment are developed. Cargo Therapeutics has raised $200 million across 1 funding round from investors including Nextech Systems, T. Rowe Price and Janus Henderson Investors. The company has 42 employees. Cargo Therapeutics offers products and services including CRG-023. Its focus areas include Life Sciences, Oncology, Drugs and Diversified. Its legal entity is CARGO Therapeutics, Inc. Its competitors include Senti Biosciences, Caribou Biosciences and Poseida Therapeutics; 3 of its 3 listed competitors have raised funding.
Company details
Cargo Therapeutics was founded in 2021 and is based in San Mateo, United States. Focus is placed on the biotechnology sector, where cell-based therapeutics are developed for cancer treatment. CAR T-cell therapies, including CD22 CAR T and multi-specific CAR T candidates, are offered for addressing hematological malignancies and solid tumors. Operations center on advancing these drug candidates through research and development.
- Headquarters San Mateo, United States
- Employees 42
- Founders Louai Labanieh, Robbie Majzner, Nancy Goodman
- Stage Acquired
- SectorsHealthcare
- Email••••••••
- Website cargo-tx.com
- Social LinkedIn X
- Acquired by Concentra Biosciences (Jul 2025)
- Legal Name Cargo Therapeutics, Inc.
- Total Equity Funding$200M (USD)
in 1 rounds
- Latest Funding Round$200M (USD), Series A
Feb 2023
- InvestorsNextech Systems
& 15 more
- Employee Count42
- Acquired byConcentra Biosciences
(Jul 2025)
Products & Services of Cargo Therapeutics
Cargo Therapeutics offers a comprehensive portfolio of products and services, including CRG-023.
Platform for developing allogeneic CAR T-cell therapies to treat cancer.
Funding Insights of Cargo Therapeutics
Cargo Therapeutics has successfully raised a total of $200M through 1 strategic funding round. The most recent funding activity was a Series A round of $200 million completed in February 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $200M
- Total Rounds 1
- Last Round Series A — $200M
- First Round $200M
(Feb 2023)
- Investors Count 15
All 1 funding rounds of Cargo Therapeutics with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Feb 2023 | $200M | Series A | – | Third Rock Ventures, RTW Investments |
16 investors in total: 16 institutional.
Investors in Cargo Therapeutics
Cargo Therapeutics has secured backing from 16 investors, including venture fund and institutional investors. Prominent investors backing the company include Nextech Systems, T. Rowe Price and Janus Henderson Investors.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Venture capital funding is provided to early-stage life science companies. | thirdrockventures.com | Boston, United States | ||
Life Sciences focused VC firm investing in the US | 2010 | rtwfunds.com | New York, United States | |
Multiple sectors are targeted for venture capital investments. | 1934 | janushenderson.com | London, United Kingdom | |
Private equity and hedge fund investments in healthcare are managed. | ally-bridge.com | Hong Kong, China | ||
Venture capital funding is provided by Samsara BioCapital in California. | samsaracap.com | Palo Alto, United States | ||
Red Tree Venture Capital is focused on life science investments. | redtreevc.com | Redwood City, United States | ||
Life science startups are accelerated through focused programs by Xontogeny. | 2016 | xontogeny.com | Boston, United States | |
PE firm investing in the US | nextechinvest.com | Zurich, Switzerland | ||
Health-tech companies are targeted for venture capital investments. | 1999 | perceptivelife.com | New York, United States | |
All-in-one practice management system for Dermatology, Ophthalmology and Plastic Surgery practices | 1997 | nextech.com | Tampa, United States |
Investor details for Cargo Therapeutics
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Cargo Therapeutics
10 people are tracked at Cargo Therapeutics (9 in leadership, 1 in team); the tracked headcount is 42.
| Name | Role | Group |
|---|---|---|
Louai Labanieh | Co-Founder | Leadership |
Robbie Majzner | Co-Founder | Leadership |
Nancy Goodman | Co-Founder | Leadership |
Beth Vasievich | Head Of Commercial Planning And Operations | Leadership |
Dina Ibrahim Lefton | Associate Director | Leadership |
Andrew Miller, PMP, MBA | Director | Strategic Operations | Leadership |
Anup Radhakrishnan | Interim Chief Executive Officer | Leadership |
Kari Leetch | Chief People Officer | Leadership |
Laura Graham | Senior Director, Corporate Counsel | Leadership |
Simran Kaur | Technical Program Manager | Team |
Complete people profiles for Cargo Therapeutics
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Cargo Therapeutics
4 dated milestones of Cargo Therapeutics across 4 years, from founding to its latest funding, stage changes and deals.
- Founded Cargo Therapeutics is founded.
- Funding First funding round of $200.0M.
- IPO Lists on the stock exchange (IPO).
- Exit Acquired by Concentra Biosciences.
Competitors of Cargo Therapeutics
Cargo Therapeutics has 3 listed competitors in our database, 3 of them funded. They include Senti Biosciences, Caribou Biosciences and Poseida Therapeutics.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| sentibio.com | 2016 | San Francisco, United States | $158M | Cell-based therapies for cancer treatment are developed. | ||
| cariboubio.com | 2011 | Berkeley, United States | $156.55M | 92 | Provider of cell therapies to treat cancer and hematologic conditions | |
| poseida.com | 2015 | San Diego, United States | $323.78M | 259 | Developer of gene therapies for treating cancer and liver orphan disease by using gene editing technologies |
Detailed competitors of Cargo Therapeutics
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Cargo Therapeutics
Websites that share an audience with Cargo Therapeutics (cargo-tx.com).
Websites whose visitors overlap most with Cargo Therapeutics. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| oncologypipeline.com | 100% | 76.4K | #510,302 | View details | |
| biopharmadive.com | 90% | 680.7K | #208,628 | View details | |
| endpts.com | 87% | 8.4K | #3,077,209 | View details | |
| fiercebiotech.com | 70% | 858.3K | #81,022 | View details | |
firstwordpharma.com | firstwordpharma.com | 52% | #237,108 | – |
Top companies in Cell Therapy
3 companies that operate in the same segment as Cargo Therapeutics (Cell Therapy) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
CAR T-cell and T-cell receptor immunotherapies for cancer are developed. | 2013 | Seattle, Washington, United States | USD 316.67 M | 520 | ||
CAR-T and TIL immunotherapies for solid tumors are developed. | 2018 | San Francisco, California, United States | USD 493 M | USD 36 K | 233 | |
Smart surgical devices for spinal surgery are developed. | 1997 | San Diego, California, United States | USD 54.1 M |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Cargo Therapeutics
Complete news archive for Cargo Therapeutics
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Cargo Therapeutics
Cargo Therapeutics was founded in 2021 and raised its 1st funding round 2 years after it was founded.
Cargo Therapeutics is headquartered in San Mateo, United States. It is registered at San Mateo, California, United States.
Cargo Therapeutics is a funded company, having raised a total of $200M across 1 funding round to date. The company's 1st funding round was a Series A of $200M, raised on Feb 2023.
Cargo Therapeutics has 42 employees.
Cargo Therapeutics was founded in 2021 and is based in San Mateo, United States. Focus is placed on the biotechnology sector, where cell-based therapeutics are developed for cancer treatment. CAR T-cell therapies, including CD22 CAR T and multi-specific CAR T candidates, are offered for addressing hematological malignancies and solid tumors. Operations center on advancing these drug candidates through research and development.
Cargo Therapeutics's top competitors include Senti Biosciences, Caribou Biosciences and Poseida Therapeutics.
Cargo Therapeutics offers CRG-023.
Cargo Therapeutics has 16 investors. Key investors include Nextech Systems, T. Rowe Price, Janus Henderson Investors, RTW Investments, and Piper Sandler.
Cargo Therapeutics operates through Cargo Therapeutics, Inc..
Yes. Cargo Therapeutics was acquired by Concentra Biosciences in July 2025.